Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Asset Writedowns and Impairment: 2009-2018

Historic Asset Writedowns and Impairment for Avadel Pharmaceuticals (AVDL) over the last 5 years, with Dec 2018 value amounting to $66.1 million.

  • Avadel Pharmaceuticals' Asset Writedowns and Impairment was N/A to $4.3 million in Q2 2014 from the same period last year, while for Jun 2014 it was $32.1 million, marking a year-over-year change of. This contributed to the annual value of $66.1 million for FY2018, which is N/A change from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Asset Writedowns and Impairment of $66.1 million as of FY2018, which was up 821.72% from $7.2 million recorded in FY2012.
  • In the past 5 years, Avadel Pharmaceuticals' Asset Writedowns and Impairment ranged from a high of $66.1 million in FY2018 and a low of $66.1 million during FY2018.
  • Its 1-year average for Asset Writedowns and Impairment is $66.1 million, with a median of $66.1 million in 2018.